Beyond Promises...
Are Over 105
Real Life Miracles
The most crucial measure of a stem cell bank is not its storage volume, but "the success of releasing cells for actual treatments" (Released Cases). THAI StemLife is proud to have brought smiles back to over 105 families.
Actual Treatment Release Records
0%
Blood Diseases
Successfully treating Thalassemia and Leukemia, establishing one of the largest patient cohorts in Asia.
0%
Brain Regeneration
Regenerative therapy for Cerebral Palsy, Traumatic Brain Injury and Autism patients.
0%
Osteoarthritis
Utilizing stem cells for knee regeneration in the elderly, backed by over 6 published research papers.
Over 105 lives SAVED!
Nothing vouches better than a release and use of a Cord Blood unit in a successful bone marrow transplantation ultimately SAVING a LIFE, something that no other private stem cell bank in Thailand has accomplished.
THAI StemLife Cord Blood Release Record as of September 2022 Most releases by a SINGLE Stem Cell Bank in Thailand, SE Asia and the whole of Asia!
Blood Stem Cell Release (PBSC)
Hematopoietic stem cells in the bloodstream are blood-forming stem cells that continuously circulate in the body in small amounts.
However, when the body receives cytokines that stimulate bone marrow activity, such as G-CSF (a naturally occurring factor that stimulates stem cell production), or during bone marrow recovery after chemotherapy, the number of these blood-forming stem cells in the bloodstream increases rapidly.
Transplanting stem cells collected from the bloodstream tends to engraft more quickly than using stem cells from bone marrow, possibly because they contain more mature blood-forming stem cells.
When we refer to 'stem cell transplants' it usually means the transplantation of stem cells from the bloodstream. Although the natural habitat of stem cells is the bone marrow, we can induce them to exit the bone marrow and enter the bloodstream, where they can be collected more easily.
Procedure for Collecting Autologous Stem Cells from the Bloodstream
Consultation
Consult with a doctor for medical history and physical examination.
Stimulation
Administer G-CSF injection for 5 days to stimulate stem cell production from the bone marrow.
Collection
Full PBSCs by apheresis and AutoMini PBSCs 350 cc blood.
Laboratory
Deliver to THAI StemLife laboratory for stem cell isolation.
Cryopreservation
Store stem cells cryogenically at a temperature of -196°C.
Retrieval
Retrieve stem cells for medical purposes.
Consultation
Consult with a doctor for medical history and physical examination.
Stimulation
Administer G-CSF injection for 5 days to stimulate stem cell production from the bone marrow.
Collection
Full PBSCs by apheresis and AutoMini PBSCs 350 cc blood.
Laboratory
Deliver to THAI StemLife laboratory for stem cell isolation.
Cryopreservation
Store stem cells cryogenically at a temperature of -196°C.
Retrieval
Retrieve stem cells for medical purposes.
Historical Release Record
The most releases by a single stem cell bank in Thailand, SE Asia, and all of Asia. A testament to our rigorous protocols meeting international standards.
40 Releases of Autologous PBSC to Self for Osteoarthritis treatments at Private Hospitals & Police General Hospital Thailand as part of our Thai Medical Council approved Osteoarthritis study that resulted in 6 peer reviewed international publications, to dated cited more than 108 times.
25 Releases of Autologous PBSC to Self for Diabetes Mellitus ulcer treatments at Private Hospitals.
Thailand as part of our NIA 2006 Top Innovation Award study. This list shows releases by THAI StemLife, to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by stem cells. In addition, banking your baby's cord blood/lining/tissue does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.
THAI StemLife provided autologous umbilical cord blood stem cells along with G-CSF in CEREBRAL PALSY. Peer review publication in 2011; to date, cited internationally 60 times.
THAI StemLife provided autologous umbilical cord blood stem cells along with G-CSF in CEREBRAL PALSY. Peer review publication in 2011; to date, cited internationally 60 times.
THAI StemLife provided autologous peripheral blood stem cells to heal DIABETIC ULCERS.
THAI StemLife provided autologous peripheral blood stem cells to heal DIABETIC ULCERS.
THAI StemLife provided Cord Blood Stem Cells from a SAVIOR sibling achieved through IVF at our sister company Superior ART, for Bone Marrow Transplantation in THALASSEMIA. To date, another 15 babies have been born at Superior ART and their cord blood stem cells have cured Thalassemia in 15 affected siblings to date! To date, 15 out of 100 successful cases worldwide have been provided by THAI StemLife
THAI StemLife provided Cord Blood Stem Cells from a SAVIOR sibling achieved through IVF at our sister company Superior ART, for Bone Marrow Transplantation in THALASSEMIA. To date, another 15 babies have been born at Superior ART and their cord blood stem cells have cured Thalassemia in 15 affected siblings to date! To date, 15 out of 100 successful cases worldwide have been provided by THAI StemLife
We provided autologous peripheral blood stem cells for bone marrow transplantation in MULTIPLE SCLEROSIS (MS).
We provided autologous peripheral blood stem cells for bone marrow transplantation in MULTIPLE SCLEROSIS (MS).
We provided autologous peripheral blood stem cells for studies in KNEE OSTEOARTHRITIS since 2013. All our six publications have been cited internationally over 140 times!
We provided autologous peripheral blood stem cells for studies in KNEE OSTEOARTHRITIS since 2013. All our six publications have been cited internationally over 140 times!
We studied how autologous peripheral blood stem cells work in CARTILAGE REGENERATION in 2014. Our publication has been cited internationally 42 times!
We studied how autologous peripheral blood stem cells work in CARTILAGE REGENERATION in 2014. Our publication has been cited internationally 42 times!
We conducted a randomized controlled study of autologous peripheral blood stem cells in KNEE OSTEOARTHRITIS that was approved by the Thai Ministry of Public Health and the Thai Medical Council. Our publication has been cited internationally 28 times!
We conducted a randomized controlled study of autologous peripheral blood stem cells in KNEE OSTEOARTHRITIS that was approved by the Thai Ministry of Public Health and the Thai Medical Council. Our publication has been cited internationally 28 times!
